Abstract:Abstract Acne vulgaris continues to result in a significant psychological and physical burden on patients, mostly occurring at an important time of psychosocial development. We would like to highlight the novel case of a 19-year-old male patient who attended the dermatology department for treatment of nodulocystic acne. On presentation, he had large cystic lesions affecting the forehead, cheeks and neck and abutting the left medial canthus. He had a background history of aplastic anaemia, treated with eltrombopag, antithymocyte globulin and ciclosporin. Unfortunately, the patient developed idiopathic intracranial hypertension (IIH) secondary to treatment with ciclosporin. Due to the severity of his IIH, treatment with isotretinoin was contraindicated. He was commenced on erythromycin 500 mg twice daily along with adapalene gel topically but had a suboptimal therapeutic response. During his care, he was admitted under the haematology team with diffuse abdominal pain and a raised lactate dehydrogenase. He was subsequently diagnosed with paroxysmal nocturnal haemoglobinuria (PNH) and was commenced on biweekly eculizumab infusions. Within 1 month, he noticed a significant improvement in his acne. He was reviewed 3 months later, and his acne was clear, with only a few scattered pustules. The patient continues to report that scattered papules and pustules appear 1–2 days before his biweekly infusions; however, these quickly resolve after infusion. Eculizumab was first approved for treating PNH in 2007 and is a recombinant humanized monoclonal antibody inhibiting complement component C5. In vitro studies investigating the role of the complement pathway were carried out in the 1970s, at which time it was thought that colonizing bacteria can activate the complement pathway through stimulation of the reticuloendothelial system. Both acne and hidradenitis suppurativa (HS) are disorders of follicular occlusion; 23–70% of patients with HS report concomitant acne. Phase IIa/IIb clinical trials of C5a inhibition have shown promise in the treatment of HS. Although the pathogeneses of both acne and HS remain distinct, there have been studies showing positive response to C5 inhibition in patients with acne, supporting the theory that perhaps complement does pay a role in acne development. The authors present this case to highlight the complement pathway as a possible alternative therapeutic target in severe nodulocystic acne.

P015 Acne: clues to the mechanism of disease

Tumor-derived Fas ligand induces toxicity in lymphoid organs and plays an important role in successful chemotherapy

Experimental induction of Proteus mirabilis cystitis in the pony and evaluation of therapy with trimethoprim-sulfadiazine.

Integrating complement into the molecular pathogenesis of Hidradenitis Suppurativa

[Three cases of pancreatic pseudocyst treated with transpapillary endoscopic management of pancreatic duct disruption after percutaneous drainage as a first-line treatment].

A Practice Approach to Acne Fulminans in Adolescents

A Case of Dissecting Cellulitis of the Scalp, Hidradenitis Suppurativa, and Conglobate Acne Successfully Treated with Secukinumab

Recent advances in understanding inflammatory acne: Deciphering the relationship between Cutibacterium acnes and Th17 inflammatory pathway

Acne fulminans treatment: case report and literature review

The effect of substitution on anticonvulsant activity of some 5,5-diphenylhydantoin derivatives.

The degree of tongue-coating reflects lingual motor function in the elderly.

Suicide Following Homicide in the Family

Autoantibodies Present in Hidradenitis Suppurativa Correlate with Disease Severity and Promote the Release of Proinflammatory Cytokines in Macrophages

Inflammasomes: emerging therapeutic targets in hidradenitis suppurativa?

PATHOGENETIC MECHANISM OF ACNE-COUPLED INFLAMMATION

Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis

Insights into acne and the skin barrier: Optimizing treatment regimens with ceramide‐containing skincare

Serum levels of hypersensitive-C-reactive protein in moderate and severe acne

Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape

Late onset isotretinoin resistant acne conglobata in a patient with acromegaly

Motor functions in rat hindlimb muscles following neonatal sciatic nerve crush